These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6358275)

  • 1. Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin.
    Jarvik LF; Read SL; Mintz J; Neshkes RE
    J Clin Psychopharmacol; 1983 Dec; 3(6):368-72. PubMed ID: 6358275
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.
    Finnerty RJ; Goldberg HL
    J Clin Psychiatry; 1981 Jul; 42(7):275-9. PubMed ID: 7240113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment orthostatic hypotension as a predictor of response to nortriptyline in geriatric depression.
    Schneider LS; Sloane RB; Staples FR; Bender M
    J Clin Psychopharmacol; 1986 Jun; 6(3):172-6. PubMed ID: 3711368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordings.
    Amin MM; Ban TA; Lehmann HE; Marcotte E
    Psychopharmacol Bull; 1978 Jan; 14(1):39-42. PubMed ID: 343149
    [No Abstract]   [Full Text] [Related]  

  • 5. Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.
    Neshkes RE; Gerner R; Jarvik LF; Mintz J; Joseph J; Linde S; Aldrich J; Conolly ME; Rosen R; Hill M
    J Clin Psychopharmacol; 1985 Apr; 5(2):102-6. PubMed ID: 3988967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is doxepin a safer tricyclic for the heart?
    Roose SP; Dalack GW; Glassman AH; Woodring S; Walsh BT; Giardina EG
    J Clin Psychiatry; 1991 Aug; 52(8):338-41. PubMed ID: 1869496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
    Ahles S; Gwirtsman H; Halaris A; Shah P; Schwarcz G; Hill MA
    J Clin Psychiatry; 1984 Nov; 45(11):460-5. PubMed ID: 6208185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxepin versus imipramine in psychoneurotic depressed patients with sleep disturbance: a double-blind study.
    Finnerty RJ; Goldberg HL; Rickels K
    J Clin Psychiatry; 1978 Dec; 39(12):852-6. PubMed ID: 721790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of clomipramine and doxepin in neurotic depression.
    Kornhaber A; Horwitz IM
    J Clin Psychiatry; 1984 Aug; 45(8):337-41. PubMed ID: 6378895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J; Seco G; Barranco M; Kyle EM
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 13. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of adjunctive imipramine in postpsychotic depression.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Casey E
    Psychopharmacol Bull; 1985; 21(1):114-6. PubMed ID: 2858903
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipramine vs. placebo studies of childhood depression: baseline predictors of response to treatment and factor analysis of presenting symptoms.
    Hughes CW; Preskorn SH; Weller E; Weller R; Hassanein R
    Psychopharmacol Bull; 1988; 24(2):275-9. PubMed ID: 3062660
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma concentrations of imipramine and clinical response among depressed outpatients.
    Matuzas W; Javaid JI; Glass R; Davis JM; Ross JA; Uhlenhuth EH
    J Clin Psychopharmacol; 1982 Apr; 2(2):140-2. PubMed ID: 7042772
    [No Abstract]   [Full Text] [Related]  

  • 18. A follow-up report and double blind comparative study of amoxapine and imipramine for the treatment of depressive inpatients.
    Eilenberg MD
    N Z Med J; 1982 Mar; 95(704):189-91. PubMed ID: 7045745
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH; Shipley JE; Peyser JM; Williams JM; Weaver LA
    Psychopharmacol Bull; 1984; 20(1):79-82. PubMed ID: 6144136
    [No Abstract]   [Full Text] [Related]  

  • 20. Imipramine for treatment of chronic depression.
    Kocsis JH; Frances A; Mann JJ; Sweeney J; Voss C; Mason B; Brown RP
    Psychopharmacol Bull; 1985; 21(3):698-700. PubMed ID: 3898184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.